A new trading day began on Monday, with Vir Biotechnology Inc (NASDAQ: VIR) stock price down -3.28% from the previous day of trading, before settling in for the closing price of $6.70. VIR’s price has ranged from $6.40 to $14.45 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 423.44% over the last five years. Meanwhile, its annual earnings per share averaged 12.21%. With a float of $87.38 million, this company’s outstanding shares have now reached $136.96 million.
The firm has a total of 408 workers. Let’s measure their productivity. In terms of profitability, gross margin is 86.84%, operating margin of -707.97%, and the pretax margin is -715.51%.
Vir Biotechnology Inc (VIR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Vir Biotechnology Inc is 36.28%, while institutional ownership is 51.31%. The most recent insider transaction that took place on Feb 26 ’25, was worth 67,402. In this transaction EVP and General Counsel of this company sold 7,373 shares at a rate of $9.14, taking the stock ownership to the 79,460 shares. Before that another transaction happened on Feb 26 ’25, when Company’s Officer proposed sale 7,373 for $9.10, making the entire transaction worth $67,094.
Vir Biotechnology Inc (VIR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.83 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.12% during the next five years compared to -18.74% drop over the previous five years of trading.
Vir Biotechnology Inc (NASDAQ: VIR) Trading Performance Indicators
Here are Vir Biotechnology Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 8.71. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.83, a number that is poised to hit -0.84 in the next quarter and is forecasted to reach -3.07 in one year’s time.
Technical Analysis of Vir Biotechnology Inc (VIR)
Analysing the last 5-days average volume posted by the [Vir Biotechnology Inc, VIR], we can find that recorded value of 1.28 million was lower than the volume posted last year of 2.08 million. As of the previous 9 days, the stock’s Stochastic %D was 30.56%. Additionally, its Average True Range was 0.43.
During the past 100 days, Vir Biotechnology Inc’s (VIR) raw stochastic average was set at 2.80%, which indicates a significant decrease from 19.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 39.80% in the past 14 days, which was lower than the 98.96% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.74, while its 200-day Moving Average is $8.53. Now, the first resistance to watch is $6.60. This is followed by the second major resistance level at $6.73. The third major resistance level sits at $6.90. If the price goes on to break the first support level at $6.30, it is likely to go to the next support level at $6.13. Should the price break the second support level, the third support level stands at $6.00.
Vir Biotechnology Inc (NASDAQ: VIR) Key Stats
With a market capitalization of 888.69 million, the company has a total of 137,143K Shares Outstanding. Currently, annual sales are 74,210 K while annual income is -521,960 K. The company’s previous quarter sales were 12,370 K while its latest quarter income was -104,590 K.
